Åžahin, U., Muik, A., Vogler, I., Derhovanessian, E., Kranz, L. M., Vormehr, M., Quandt, J., Bidmon, N., Ulges, A., Baum, A., Pascal, K. E., Maurus, D., Brachtendorf, S., Lörks, V., Sikorski, J., Koch, P., Hilker, R., Becker, D., Eller, A., Grützner, J., Tonigold, M., Boesler, C., Rosenbaum, C., Heesen, L., Kühnle, M., Poran, A., Dong, J. Z., Luxemburger, U., Kemmer-Brück, A., Langer, D., Bexon, M., Bolte, S., Palanche, T., Schultz, A., Baumann, S., Mahiny, A. J., Boros, G., Reinholz, J., Szabó, G. T., Karikó, K., Shi, P., Fontes-Garfias, C., Perez, J. L., Cutler, M., Cooper, D., Kyratsous, C. A., Dormitzer, P. R., Jansen, K. U., Türeci, Ã. (2025). Author Correction: BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature. https://doi.org/10.1038/s41586-025-09355-7